| 000 | 01777 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250517191319.0 | ||
| 264 | 0 | _c20181119 | |
| 008 | 201811s 0 0 eng d | ||
| 022 | _a1179-1950 | ||
| 024 | 7 |
_a10.1007/s40265-017-0851-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhanel, George G | |
| 245 | 0 | 0 |
_aImipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations. _h[electronic resource] |
| 260 |
_bDrugs _cJan 2018 |
||
| 300 |
_a65-98 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xchemistry |
| 650 | 0 | 4 |
_aAzabicyclo Compounds _xchemistry |
| 650 | 0 | 4 |
_aBoronic Acids _xchemistry |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 |
_aDrug Resistance, Bacterial _xdrug effects |
| 650 | 0 | 4 |
_aHeterocyclic Compounds, 1-Ring _xchemistry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImipenem _xchemistry |
| 650 | 0 | 4 |
_aIntraabdominal Infections _xdrug therapy |
| 650 | 0 | 4 | _aMeropenem |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 |
_aThienamycins _xchemistry |
| 650 | 0 | 4 |
_abeta-Lactamase Inhibitors _xchemistry |
| 700 | 1 | _aLawrence, Courtney K | |
| 700 | 1 | _aAdam, Heather | |
| 700 | 1 | _aSchweizer, Frank | |
| 700 | 1 | _aZelenitsky, Sheryl | |
| 700 | 1 | _aZhanel, Michael | |
| 700 | 1 | _aLagacé-Wiens, Philippe R S | |
| 700 | 1 | _aWalkty, Andrew | |
| 700 | 1 | _aDenisuik, Andrew | |
| 700 | 1 | _aGolden, Alyssa | |
| 700 | 1 | _aGin, Alfred S | |
| 700 | 1 | _aHoban, Daryl J | |
| 700 | 1 | _aLynch, Joseph P | |
| 700 | 1 | _aKarlowsky, James A | |
| 773 | 0 |
_tDrugs _gvol. 78 _gno. 1 _gp. 65-98 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s40265-017-0851-9 _zAvailable from publisher's website |
| 999 |
_c27879303 _d27879303 |
||